| Market Cap | ₹22Cr |
| ROE | 8.65% |
| P/E Ratio(TTM) | 22.91 |
| EPS(TTM) | 3.25 |
| P/B Ratio | 1.98 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.32 |
| Book Value | 37.58 |
| Debt to Equity | 0.18 |
| Face Value | 10 |
| Parent Organisation | Ishita Drugs & Industries Limited |
| Managing Director | Mr. Jagdish Agrawal |
| Founded | 1992 |
| BSE Symbol | 524400 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 68.95 | ||
| Neuland Laboratories | NA (0.00%) | 90.67 | ||
| Jubilant Pharmova | NA (0.00%) | 36.21 | ||
| Acutaas Chemicals | NA (0.00%) | 62.83 |